TP53 and hepatocellular carcinoma: In addition, PLK1 could be highly co-expressed with BIRC5 in p53-mutated HCC, and thereby co-inhibition of PLK1 and BIRC5 synergistically compromised the viability of p53-mutated HCC cells in vitro and in vivo (51).